The effect of hypocretin replacement therapy in a 3-year-old Weimaraner with narcolepsy.

@article{Schatzberg2004TheEO,
  title={The effect of hypocretin replacement therapy in a 3-year-old Weimaraner with narcolepsy.},
  author={S. Schatzberg and K. Cutter-Schatzberg and D. Nydam and J. Barrett and R. Penn and J. Flanders and A. Delahunta and L. Lin and E. Mignot},
  journal={Journal of veterinary internal medicine},
  year={2004},
  volume={18 4},
  pages={
          586-8
        }
}
  • S. Schatzberg, K. Cutter-Schatzberg, +6 authors E. Mignot
  • Published 2004
  • Medicine
  • Journal of veterinary internal medicine
  • Both the number ofattacks (NA) and elapsed time in collapse (ET) were mea-sured as an index of cataplexy severity. Further supportingthe diagnosis of narcolepsy and cataplexy, we measured adramatic response to IV yohimbine (Figs 1, 2; NA and ETwith no treatment: median, 6 collapses and 50.5 seconds,respectively; NA and ET with 0.048 mg/kg IV: median, 0.5collapses [P 5 .004] and 9.5 seconds [P 5 .005, Wilcoxonrank sum test], respectively). 
    43 Citations

    Topics from this paper.

    Emerging therapies in narcolepsy-cataplexy.
    • 104
    • PDF
    Immunotherapy in Narcolepsy
    Treatment of cataplexy
    • 2
    Effect of clomipramine in a dog with cataplexy
    Narkolepsja u dzieci
    Recent Advances in the Treatment of Narcolepsy
    • 36
    Therapeutic advances in narcolepsy.
    • 62

    References

    SHOWING 1-10 OF 14 REFERENCES
    PHARMACOLOGICAL ASPECTS OF HUMAN AND CANINE NARCOLEPSY
    • 389
    Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep.
    • 45